Skip to main content
Top
Published in: Journal of the International Society of Sports Nutrition 1/2011

Open Access 01-12-2011 | Research article

Perceived protein needs and measured protein intake in collegiate male athletes: an observational study

Authors: Elizabeth A Fox, Jennifer L McDaniel, Anthony P Breitbach, Edward P Weiss

Published in: Journal of the International Society of Sports Nutrition | Issue 1/2011

Login to get access

Abstract

Background

Protein needs for athletes are likely higher than those for the general population. However, athletes may perceive their protein needs to be excessively high. The purpose of this research was to compare collegiate athletes' perceived protein needs and measured protein intake to the recommended protein intake (RDI) for healthy adults (i.e. 0.8 g/kg/d) and to the maximum beneficial level for strength-trained athletes (i.e. 2.0 g/kg/day).

Methods

Perceived protein needs were quantified in 42 strength-trained collegiate male athletes by using a survey that asked the athletes to provide their perception about protein needs in specific quantitative terms (i.e. g/kg/d). Perceived protein needs were also determined by having the athletes select a daylong menu that they perceived to have adequate protein content from a collection of 5 isoenergetic menus, which differed in terms of protein content. Actual protein intake was quantified using 3-day food records and nutrient analysis. Single sample t-tests were used to compare protein intake and perceived protein needs to 0.8 g/kg/day and 2.0 g/kg/day.

Results

When asked to provide, in quantitative terms, protein needs for athletes, 67% of the athletes indicated "do not know." Of the remaining 33% of athletes, all gave values greater than 2.0 g/kg/d (mean 21.5 ± 11.2 g/kg/d, p = 0.14 vs. 2.0 g/kg/d). Based on the menu selection method for determining perceived protein needs, the athletes indicated that their protein needs were 2.4 ± 0.2 g/kg/d, which was greater than the RDI for protein (p < 0.0001) and tended to be greater than the maximally beneficial protein intake of 2.0 g/kg/d (p = 0.13). Measured protein intake was 2.0 ± 0.1 g/kg/d, which was greater than the RDI (p < 0.0001) but not different from the maximally beneficial protein intake of 2.0 g/kg/d (p = 0.84).

Conclusions

Male collegiate athletes recognize that their protein needs are higher than that of the general population and consume significantly more protein than recommended in the RDI. However, it also appears that athletes are not aware of objective recommendations for protein intake and may perceive their needs to be excessively high. This study highlights the need for nutrition education in collegiate athletes, in particular nutrition education on macronutrient distribution and protein needs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fulgoni VL: Current protein intake in America: analysis of the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr. 2008, 87: 1554S-1557S.PubMed Fulgoni VL: Current protein intake in America: analysis of the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr. 2008, 87: 1554S-1557S.PubMed
2.
go back to reference Cole CR, Salvaterra GF, Davis JE, Borja ME, Powell LM, Dubbs EC, Bordi PL: Evaluation of dietary practices of national collegiate athletic association division I football players. J Strength Cond. 2005, 19: 490-494. Cole CR, Salvaterra GF, Davis JE, Borja ME, Powell LM, Dubbs EC, Bordi PL: Evaluation of dietary practices of national collegiate athletic association division I football players. J Strength Cond. 2005, 19: 490-494.
3.
go back to reference Jonnalagadda SS, Rosenbloom CA, Skinner R: Dietary practice, attitudes, and physiological status of collegiate freshman football players. J Strength Cond. 2001, 15: 507-513. Jonnalagadda SS, Rosenbloom CA, Skinner R: Dietary practice, attitudes, and physiological status of collegiate freshman football players. J Strength Cond. 2001, 15: 507-513.
4.
go back to reference Campbell B, Kreider RB, Ziegenfuss T, La Bounty P, Roberts M, Burke D, Landis J, Lopez H, Antonio J: International Society of Sports Nutrition position stand: protein and exercise. Int J Sports Nutr. 2007, 4: 8-10.1186/1550-2783-4-8.CrossRef Campbell B, Kreider RB, Ziegenfuss T, La Bounty P, Roberts M, Burke D, Landis J, Lopez H, Antonio J: International Society of Sports Nutrition position stand: protein and exercise. Int J Sports Nutr. 2007, 4: 8-10.1186/1550-2783-4-8.CrossRef
5.
go back to reference Lemon P, Tarnopolsky MA, MacDougall JD, Atkinson SA: Protein requirements and muscle mass/strength changes in novice body builders. J Appl Phys. 1992, 73: 767-775. Lemon P, Tarnopolsky MA, MacDougall JD, Atkinson SA: Protein requirements and muscle mass/strength changes in novice body builders. J Appl Phys. 1992, 73: 767-775.
6.
go back to reference Tarnopolsky MA, Atkinson SA, MacDougall JD, Chesley A, Phillips S, Schwarcz HP: Evaluation of protein requirements for trained strength athletes. J Appl Physiol. 1992, 73: 1986-1995.PubMed Tarnopolsky MA, Atkinson SA, MacDougall JD, Chesley A, Phillips S, Schwarcz HP: Evaluation of protein requirements for trained strength athletes. J Appl Physiol. 1992, 73: 1986-1995.PubMed
7.
go back to reference American College of Sports Medicine: ACSM's Guidelines for Exercise Testing and Prescription. 2010, Baltimore: Wilson & Wilson, 8 American College of Sports Medicine: ACSM's Guidelines for Exercise Testing and Prescription. 2010, Baltimore: Wilson & Wilson, 8
8.
go back to reference Food and Nutrition Board: Dietary Reference Intake for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. 2005, Washington D.C.: The National Academies Press Food and Nutrition Board: Dietary Reference Intake for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. 2005, Washington D.C.: The National Academies Press
9.
go back to reference Rodriguez NR, DiMarco NM, Langley S, American Dietetic Association, Dietetians of Canada, American College of Sports Medicine: Position of the American Dietetic Association, Dietitians of Canada, and the American College of Sports Medicine: Nutrition and athletic performance. J Am Diet Assoc. 2009, 109: 509-527.CrossRefPubMed Rodriguez NR, DiMarco NM, Langley S, American Dietetic Association, Dietetians of Canada, American College of Sports Medicine: Position of the American Dietetic Association, Dietitians of Canada, and the American College of Sports Medicine: Nutrition and athletic performance. J Am Diet Assoc. 2009, 109: 509-527.CrossRefPubMed
10.
go back to reference Wilson J, Wilson GJ: Contemporary issues in protein requirements and consumption for resistance trained athletes. J Int Soc Sports Nutr. 2006, 3: 7-27. 10.1186/1550-2783-3-1-7.PubMedCentralCrossRefPubMed Wilson J, Wilson GJ: Contemporary issues in protein requirements and consumption for resistance trained athletes. J Int Soc Sports Nutr. 2006, 3: 7-27. 10.1186/1550-2783-3-1-7.PubMedCentralCrossRefPubMed
11.
go back to reference Consolazio CF, Johnson HL, Nelson RA, Dramise JG, Skala JH: Protein metabolism during intensive physical training in the young adult. Am J Clin Nutr. 1975, 28: 29-35.PubMed Consolazio CF, Johnson HL, Nelson RA, Dramise JG, Skala JH: Protein metabolism during intensive physical training in the young adult. Am J Clin Nutr. 1975, 28: 29-35.PubMed
12.
go back to reference Tarnopolsky MA, MacDougall JD, Atkinson SA: Influence of protein intake and training status on nitrogen balance and lean body mass. J Appl Physiol. 1988, 64: 187-193.PubMed Tarnopolsky MA, MacDougall JD, Atkinson SA: Influence of protein intake and training status on nitrogen balance and lean body mass. J Appl Physiol. 1988, 64: 187-193.PubMed
13.
go back to reference Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO: Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell. 2008, 7: 681-687. 10.1111/j.1474-9726.2008.00417.x.PubMedCentralCrossRefPubMed Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO: Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell. 2008, 7: 681-687. 10.1111/j.1474-9726.2008.00417.x.PubMedCentralCrossRefPubMed
14.
go back to reference Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, Overvad K, Grønbaek H, Tjønneland A, Halkjaer J, Dossus L, Boeing H, Kröger J, Trichopoulou A, Dilis V, Trichopoulos D, Boutron-Ruault MC, De Lauzon B, Clavel-Chapelon F, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Vrieling A, van Gils CH, Peeters PH, Gram IT, Skeie G, Lund E: The association between diet and serum concentrations of IGF-1, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Caner and Nutrition. Cancer Epidemiol Biomarkers Prev. 2009, 18: 1333-1340. 10.1158/1055-9965.EPI-08-0781.CrossRefPubMed Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, Overvad K, Grønbaek H, Tjønneland A, Halkjaer J, Dossus L, Boeing H, Kröger J, Trichopoulou A, Dilis V, Trichopoulos D, Boutron-Ruault MC, De Lauzon B, Clavel-Chapelon F, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Vrieling A, van Gils CH, Peeters PH, Gram IT, Skeie G, Lund E: The association between diet and serum concentrations of IGF-1, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Caner and Nutrition. Cancer Epidemiol Biomarkers Prev. 2009, 18: 1333-1340. 10.1158/1055-9965.EPI-08-0781.CrossRefPubMed
15.
go back to reference Aleman A, Torres-Aleman I: Circulating insulin-like growth factor 1 and cognitive function: neuromodulation throughout the lifespan. Prog Neurobiol. 2009, 89: 256-65. 10.1016/j.pneurobio.2009.07.008.CrossRefPubMed Aleman A, Torres-Aleman I: Circulating insulin-like growth factor 1 and cognitive function: neuromodulation throughout the lifespan. Prog Neurobiol. 2009, 89: 256-65. 10.1016/j.pneurobio.2009.07.008.CrossRefPubMed
16.
go back to reference Colao A: The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol. 2008, 69: 347-58. 10.1111/j.1365-2265.2008.03292.x.CrossRef Colao A: The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol. 2008, 69: 347-58. 10.1111/j.1365-2265.2008.03292.x.CrossRef
17.
18.
go back to reference Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, Boeing H, Pischon T, Panico S, Agnoli C, Palli D, Tumino R, Vineis P, Peeters PH, van Gils CH, Bueno-de-Mesquita BH, Vrieling A, Allen NE, Roddam A, Bingham S, Khaw KT, Manjer J, Borgquist S, Dumeaux V, Torhild Gram I, Lund E, Trichopoulou A, Makrygiannis G, Benetou V, Molina E: Serum levels of IGF-1, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer. 2010, 126 (7): 1702-15.PubMed Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, Boeing H, Pischon T, Panico S, Agnoli C, Palli D, Tumino R, Vineis P, Peeters PH, van Gils CH, Bueno-de-Mesquita BH, Vrieling A, Allen NE, Roddam A, Bingham S, Khaw KT, Manjer J, Borgquist S, Dumeaux V, Torhild Gram I, Lund E, Trichopoulou A, Makrygiannis G, Benetou V, Molina E: Serum levels of IGF-1, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer. 2010, 126 (7): 1702-15.PubMed
19.
go back to reference Gallagher EJ, LeRoith D: The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 2010, 21: 610-8. 10.1016/j.tem.2010.06.007.PubMedCentralCrossRefPubMed Gallagher EJ, LeRoith D: The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 2010, 21: 610-8. 10.1016/j.tem.2010.06.007.PubMedCentralCrossRefPubMed
20.
go back to reference Moschos SJ, Mantzoros CS: The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology. 2002, 63: 317-32. 10.1159/000066230.CrossRefPubMed Moschos SJ, Mantzoros CS: The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology. 2002, 63: 317-32. 10.1159/000066230.CrossRefPubMed
21.
go back to reference Voskuil DW, Vrieling A, van't Veer LJ, Kampman E, Rookus MA: The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. Cancer Epidemiol Biomarkers Prev. 2005, 14: 195-203.PubMed Voskuil DW, Vrieling A, van't Veer LJ, Kampman E, Rookus MA: The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. Cancer Epidemiol Biomarkers Prev. 2005, 14: 195-203.PubMed
22.
go back to reference Yu H, Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000, 92: 1472-89. 10.1093/jnci/92.18.1472.CrossRefPubMed Yu H, Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000, 92: 1472-89. 10.1093/jnci/92.18.1472.CrossRefPubMed
23.
go back to reference Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Langer CJ, Gualberto A: Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin. J Thorac Oncol. 2009, 4: 1397-403. 10.1097/JTO.0b013e3181ba2f1d.PubMedCentralCrossRefPubMed Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Langer CJ, Gualberto A: Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin. J Thorac Oncol. 2009, 4: 1397-403. 10.1097/JTO.0b013e3181ba2f1d.PubMedCentralCrossRefPubMed
24.
go back to reference Fuchs CS, Goldberg RM, Sargent DJ, Meyerhardt JA, Wolpin BM, Green EM, Pitot HC, Pollak M: Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741. Clin Cancer Res. 2008, 14: 8263-9. 10.1158/1078-0432.CCR-08-0480.PubMedCentralCrossRefPubMed Fuchs CS, Goldberg RM, Sargent DJ, Meyerhardt JA, Wolpin BM, Green EM, Pitot HC, Pollak M: Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741. Clin Cancer Res. 2008, 14: 8263-9. 10.1158/1078-0432.CCR-08-0480.PubMedCentralCrossRefPubMed
Metadata
Title
Perceived protein needs and measured protein intake in collegiate male athletes: an observational study
Authors
Elizabeth A Fox
Jennifer L McDaniel
Anthony P Breitbach
Edward P Weiss
Publication date
01-12-2011
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1550-2783-8-9

Other articles of this Issue 1/2011

Journal of the International Society of Sports Nutrition 1/2011 Go to the issue